Teva to pay NIS 75 million to Israel authorities to settle foreign bribe claims | The Times of Israel
Teva Pharmaceutical Industries LTD | PDF | Generic Drug | American Depositary Receipt
Complete Response Letter Received for AVT02 Biologics License Application
Teva Pharmaceutical to Nominate Four New Directors - WSJ
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Amit Hazan - Head of Corporate Finance & Banking Relations - Teva Pharmaceuticals | LinkedIn
New branded drugs helping Teva Pharm move closer to growth | Reuters
Teva Pharmaceutical net income 2006-2022 | Statista
Teva Pharma: Your Brief On The Big Earnings Report Coming In February (NYSE: TEVA) | Seeking Alpha
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook
Teva Pharmaceutical Industries Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Teva banks on blockbuster Austedo sales as COVID-19, Copaxone generics take their toll | Fierce Pharma
Domingo Rojas - Finance Manager - Teva Pharmaceuticals | LinkedIn
Teva Reports First Quarter 2021 Financial Results | Business Wire
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Investors question green tint of Teva's $5bn sustainability bond | Financial Times
Teva Pharmaceutical Industries Limited - AnnualReports.com
Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results | AlphaStreet
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
A Deep Dive into Teva Pharma Financials Shows Significant Weakness and Optimism | BioSpace
Teva Ramps Up Sales With Medis, Respiratory Units - Bloomberg
Teva buys Anda for $500 million - ISRAEL21c
Teva Reports Third Quarter 2021 Financial Results | Business Wire
Teva Pharmaceutical: Investment Opportunity During Fed Rate Hike (NYSE:TEVA) | Seeking Alpha
